Refining Our Strategy in Alzheimer Disease: Amyloid, Tau, and Beyond
Reisa Sperling, MD sat down with NeurologyLive to discuss why she thinks investigational drugs for Alzheimer disease are failing, and what she feels are the most promising treatment avenues.
Reisa Sperling, MD: Advances in Early Detection of Alzheimer Disease
Sperling sat down with NeurologyLive at AAIC 2019 to discuss her thoughts on efforts to detect and treat Alzheimer early on in the disease.
2 Commerce Drive Cranbury, NJ 08512